Trial intelligence / Profile preview

Instanyl for acute renal colic pain and prevention of hospitalization

2012-001370-28Phase 2Active

Sponsor
Isala
Start
Oct 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Renal colic comparing Instanyl intranasal with Placebo intranasal (2 arms). Primary endpoint: Pain reduction at 20 minutes on VAS. Started Oct 2012; status: active.

02

Drugs

fentanyl
03

Conditions

Renal colic

Beyond the preview

Go deeper on 2012-001370-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001370-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call